Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Condition: Mycosis Fungoides Intervention: Drug: Brentuximab vedotin Sponsors: M.D. Anderson Cancer Center; Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides
Condition: Mycosis Fungoides Intervention: Drug: Chlormethine Sponsors: Centre for Human Drug Research, Netherlands; Recordati Rare Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials